Cargando…
Recombinant Human Thyrotropin-Aided Radioiodine Therapy in Patients with Metastatic Differentiated Thyroid Carcinoma
Our aim was to test the efficacy of 131-I therapy (RIT) using recombinant human TSH (rhTSH) in patients with differentiated thyroid carcinoma (DTC) in whom endogenous TSH stimulation was not an option due to the poor patient's physical condition or due to the disease progression during L-thyrox...
Autores principales: | Zagar, Ivana, Schwarzbartl-Pevec, Andreja A., Vidergar-Kralj, Barbara, Horvat, Rika, Besic, Nikola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159002/ https://www.ncbi.nlm.nih.gov/pubmed/21876838 http://dx.doi.org/10.1155/2012/670180 |
Ejemplares similares
-
Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: a single-institution experience
por: Besic, Nikola, et al.
Publicado: (2016) -
Treatment and outcome of patients with Graves’ disease and metastatic differentiated thyroid cancer
por: Besic, Nikola, et al.
Publicado: (2023) -
Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report
por: Besic, Nikola, et al.
Publicado: (2021) -
Recombinant Human Thyrotropin-Aided Radioiodine Therapy in Tracheal Obstruction by an Invading Well-Differentiated Thyroid Carcinoma
por: Pontikides, Nickolaos, et al.
Publicado: (2013) -
Neoadjuvant chemotherapy in 13 patients with locally advanced poorly differentiated thyroid carcinoma based on Turin proposal - a single institution experience
por: Besic, Nikola, et al.
Publicado: (2015)